These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2424021)

  • 21. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.
    Lovelace LL; Cooper CL; Sodetz JM; Lebioda L
    J Biol Chem; 2011 May; 286(20):17585-92. PubMed ID: 21454577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does complement kill E. coli by producing transmural pores?
    Born J; Bhakdi S
    Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The architectural transition of human complement component C9 to poly(C9).
    DiScipio RG; Berlin C
    Mol Immunol; 1999 Jun; 36(9):575-85. PubMed ID: 10499811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
    Tomlinson S; Taylor PW; Morgan BP; Luzio JP
    Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of activation of the human terminal complement pathway by ELISA.
    Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA
    J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane pore formation by human complement: functional importance of the transmembrane β-hairpin (TMH) segments of C8α and C9.
    Weiland MH; Qian Y; Sodetz JM
    Mol Immunol; 2014 Feb; 57(2):310-6. PubMed ID: 24239861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional domains of the alpha subunit of the eighth component of human complement: identification and characterization of a distinct binding site for the gamma chain.
    Brickner A; Sodetz JM
    Biochemistry; 1985 Aug; 24(17):4603-7. PubMed ID: 4063342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation-dependent epitopes in the terminal complement pathway.
    Mollnes TE; Lea T; Tschopp J
    Complement Inflamm; 1989; 6(3):223-35. PubMed ID: 2472924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors.
    Davé SJ; Sodetz JM
    J Immunol; 1990 Apr; 144(8):3087-90. PubMed ID: 2324496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the specific association of the eighth and ninth components of human complement: identification of a direct role for the alpha subunit of C8.
    Stewart JL; Sodetz JM
    Biochemistry; 1985 Aug; 24(17):4598-602. PubMed ID: 4063341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
    Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.